Federated Hermes
ARCT icon

Federated Hermes’s Arcturus Therapeutics ARCT Stock Holding History

Federated Hermes’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Hold
3,303,640
– – 0.03% 471
2026
Q1 		$25.5M Hold
3,303,640
– – 0.04% 412
2025
Q4 		$20.3M Sell
3,303,640
-1,390,420
-30% -$15M 0.03% 456
2025
Q3 		$86.5M Hold
4,694,060
– – 0.15% 164
2025
Q2 		$61.1M Hold
4,694,060
– – 0.12% 222
2025
Q1 		$49.7M Hold
4,694,060
– – 0.11% 237
2024
Q4 		$79.7M Hold
4,694,060
– – 0.17% 155
2024
Q3 		$109M Hold
4,694,060
– – 0.24% 102
2024
Q2 		$114M Sell
4,694,060
-1,312
-0% -$39.8K 0.27% 85
2024
Q1 		$159M Sell
4,695,372
-16,140
-0.3% -$572K 0.37% 54
2023
Q4 		$149M Hold
4,711,512
– – 0.37% 57
2023
Q3 		$120M Sell
4,711,512
-66,988
-1% -$2.06M 0.32% 67
2023
Q2 		$137M Hold
4,778,500
– – 0.34% 58
2023
Q1 		$115M Buy
4,778,500
+538,946
+13% +$9.67M 0.29% 70
2022
Q4 		$71.9M Buy
4,239,554
+672,057
+19% +$11.7M 0.2% 115
2022
Q3 		$52.9M Buy
3,567,497
+6,400
+0.2% +$107K 0.15% 175
2022
Q2 		$56.1M Sell
3,561,097
-200,803
-5% -$3.94M 0.15% 178
2022
Q1 		$101M Buy
3,761,900
+66,971
+2% +$1.71M 0.23% 116
2021
Q4 		$137M Buy
3,694,929
+649,641
+21% +$26.5M 0.25% 103
2021
Q3 		$146M Buy
3,045,288
+17,288
+0.6% +$775K 0.28% 96
2021
Q2 		$102M Sell
3,028,000
-175,000
-5% -$5.92M 0.19% 148
2021
Q1 		$132M Sell
3,203,000
-249,810
-7% -$14.9M 0.26% 95
2020
Q4 		$150M Buy
3,452,810
+2,076,135
+151% +$141M 0.31% 78
2020
Q3 		$59.1M Buy
1,376,675
+761,631
+124% +$37.8M 0.14% 174
2020
Q2 		$28.7M Buy
+615,044
New +$21.2M 0.07% 312

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Federated Hermes's ARCT Position: Q2 2026 in Review

Federated Hermes held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 3,303,640 shares worth $22.2M. The position accounts for 0.03% of the portfolio, ranked #471.

Federated Hermes first reported a position in ARCT in Q2 2020 and has held it in 25 quarters since. The position peaked at $159M in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Federated Hermes held 3,303,640 shares of Arcturus Therapeutics worth $22.2M as of Q2 2026.
  • Federated Hermes left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #471 holding.
  • Federated Hermes first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Federated Hermes's Arcturus Therapeutics position peaked at $159M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.